ScholarIQanswers from OpenAlex

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer

PaperCitations, authors & open-access status

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer have?

ScholarIQcitation count

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer has 5,784 citations in the OpenAlex counts ScholarIQ stores.

When was Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer published?

ScholarIQyear

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer has 2006 year in the ScholarIQ index.

What is the open-access status of Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer?

ScholarIQoa status

Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer has bronze oa status in the ScholarIQ index.

What is the DOI of Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer?

ScholarIQdoi

The DOI for Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer is on the source record.

What is the PMID of Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer?

ScholarIQpmid

The PMID for Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer is on the source record.

What is the OpenAlex record for Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer?

ScholarIQopenalex

The OpenAlex for Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial